Shibaki R, Ozawa Y, Noguchi S, Murakami Y, Takase E, Azuma Y, Maebeya M,Sugimoto T, Hayata A, Hayakawa T, Tamaki S, Nakanishi M, Teraoka S, Akamatsu H. Impact of pre-existing interstitial lung abnormal shadow on lung injury development and severity in patients of non-small cell lung cancer treated with osimertinib. Cancer Med, 11; 3743-50, 2022
Harutani Y, Ozawa Y, Murakami E, Sato K, Oyanagi J, Akamatsu H, Yoshikawa T, Shibaki R, Sugimoto T, Furuta K, Teraoka S, Tokudome N, Hayata A, Ueda H, Nakanishi M, Koh Y, Yamamoto N. Pre-treatment serum protein levels predict survival of non-small cell lung cancer patients without durable clinical benefit by PD-1/L1 inhibitors. Cancer Immunol Immunother, 71; 2109-16, 2022
Miura S, Koh Y, Azuma K, Yoshioka H, Koyama K, Teraoka S, Ishii H, Kibata K, Ozawa Y, Tokito T, Oyanagi J, Shimokawa T, Kurata T, Yamamoto N, and Tanaka H Afatinib plus osimertinib in the treatment of osimertinib-resistant non-small cell lung carcinoma: a phase I clinical trial. BMC Cancer, 23; 6. doi: 10.1186/s12885-022-10467-w., 2023
学会報告
年次学術集会
Liu SV, Lu S, Soo RA, Hong MH, Lee JS, Bryl M, Dumoulin DW, Rittmeyer A, Chiu C, Ozyilkan O, Navarro A, Novello S, Ozawa Y, Meng R, Hoang T, Lee A, Wen X, Huang M, Reck M. SKYSCRAPER-02: Primary results of a phase III, randomized, double-blind, placebo-controlled study of atezolizumab (atezo) + carboplatin + etoposide (CE) with or without tiragolumab (tira) in patients (pts) with untreated extensive-stage small cell lung cancer (ES-SCLC). American Society of Clinical Oncology Annual Meeting (Chicago), Oral presentation, 2022
Takase E, Akamatsu H, Teraoka S, Nakaguchi N, Tanaka M, Kaki T, Sato K, Murakami E, Sugimoto T, Shibaki R, Fujimoto D, Hayata A, Tokudome N, Ozawa Y, Nakanishi M, Koh Y, Kanai K, Shimokawa T, Yamamoto N. A phase II study of high-flow nasal cannula as palliative care in advanced cancer patients. European Society of Medical Oncology Congress (Paris), 2022
池田彗、小澤 雄一、長瀬 通隆、青儀 健二郎、大西 幸次、細田 悦子、立石 清一郎、高橋 都、武田 晃司、澤 祥幸. 西日本がん研究機構が実施する、がん治療と仕事の両立支援エキスパート養成研修会 Expert training workshop on support for balancing cancer treatment and work organized by West Japan Oncology Group. 第20回日本臨床腫瘍学会学術集会 (福岡), 2023
